These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11579460)

  • 1. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
    Scheil S; Brüderlein S; Liehr T; Starke H; Herms J; Schulte M; Möller P
    Genes Chromosomes Cancer; 2001 Nov; 32(3):203-11. PubMed ID: 11579460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 7 abnormalities are common in chordomas.
    Brandal P; Bjerkehagen B; Danielsen H; Heim S
    Cancer Genet Cytogenet; 2005 Jul; 160(1):15-21. PubMed ID: 15949565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New candidate chromosomal regions for chordoma development.
    Bayrakli F; Guney I; Kilic T; Ozek M; Pamir MN
    Surg Neurol; 2007 Oct; 68(4):425-30; discussion 430. PubMed ID: 17714767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumors?
    Sawyer JR; Husain M; Al-Mefty O
    Neurosurg Focus; 2001 Mar; 10(3):E6. PubMed ID: 16734409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined binary ratio labeling fluorescence in situ hybridization analysis of chordoma.
    Kuźniacka A; Mertens F; Strömbeck B; Wiegant J; Mandahl N
    Cancer Genet Cytogenet; 2004 Jun; 151(2):178-81. PubMed ID: 15172757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of histopathological parameters, genome-wide copy number alterations, and variants in genes involved in cell cycle regulation in chordomas of the skull base and sacrum.
    Salle H; Durand S; Durand K; Bourthoumieu S; Lemnos L; Robert S; Pollet J; Passeri T; Khalil W; Froelich S; Adle-Biassette H; Labrousse F
    J Neuropathol Exp Neurol; 2023 Mar; 82(4):312-323. PubMed ID: 36779322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1.
    Rinner B; Froehlich EV; Buerger K; Knausz H; Lohberger B; Scheipl S; Fischer C; Leithner A; Guelly C; Trajanoski S; Szuhai K; Liegl B
    Int J Oncol; 2012 Feb; 40(2):443-51. PubMed ID: 22002331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.
    Presneau N; Shalaby A; Ye H; Pillay N; Halai D; Idowu B; Tirabosco R; Whitwell D; Jacques TS; Kindblom LG; Brüderlein S; Möller P; Leithner A; Liegl B; Amary FM; Athanasou NN; Hogendoorn PC; Mertens F; Szuhai K; Flanagan AM
    J Pathol; 2011 Feb; 223(3):327-35. PubMed ID: 21171078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First cytogenetic study of a recurrent familial chordoma of the clivus.
    Dalprà L; Malgara R; Miozzo M; Riva P; Volonte M; Larizza L; Fuhrman Conti AM
    Int J Cancer; 1999 Mar; 81(1):24-30. PubMed ID: 10077147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma.
    Zunino A; Viaggi S; Ottaggio L; Fronza G; Schenone A; Roncella S; Abbondandolo A
    Haematologica; 2000 Mar; 85(3):250-5. PubMed ID: 10702812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
    Wang L; Zehir A; Nafa K; Zhou N; Berger MF; Casanova J; Sadowska J; Lu C; Allis CD; Gounder M; Chandhanayingyong C; Ladanyi M; Boland PJ; Hameed M
    Genes Chromosomes Cancer; 2016 Jul; 55(7):591-600. PubMed ID: 27072194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.
    Kitamura Y; Sasaki H; Kimura T; Miwa T; Takahashi S; Kawase T; Yoshida K
    J Neuropathol Exp Neurol; 2013 Sep; 72(9):816-23. PubMed ID: 23965741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
    Shalaby A; Presneau N; Ye H; Halai D; Berisha F; Idowu B; Leithner A; Liegl B; Briggs TR; Bacsi K; Kindblom LG; Athanasou N; Amary MF; Hogendoorn PC; Tirabosco R; Flanagan AM
    J Pathol; 2011 Feb; 223(3):336-46. PubMed ID: 21171079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic and molecular cytogenetic analysis of sacral chordoma.
    Bridge JA; Pickering D; Neff JR
    Cancer Genet Cytogenet; 1994 Jul; 75(1):23-5. PubMed ID: 8039159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation.
    Hallor KH; Staaf J; Jönsson G; Heidenblad M; Vult von Steyern F; Bauer HC; Ijszenga M; Hogendoorn PC; Mandahl N; Szuhai K; Mertens F
    Br J Cancer; 2008 Jan; 98(2):434-42. PubMed ID: 18071362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal abnormalities in two chordomas.
    Gibas Z; Miettinen M; Sandberg AA
    Cancer Genet Cytogenet; 1992 Feb; 58(2):169-73. PubMed ID: 1551083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of chordoma.
    Scheil-Bertram S; Kappler R; von Baer A; Hartwig E; Sarkar M; Serra M; Brüderlein S; Westhoff B; Melzner I; Bassaly B; Herms J; Hugo HH; Schulte M; Möller P
    Int J Oncol; 2014 Apr; 44(4):1041-55. PubMed ID: 24452533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization.
    Shen H; Zhu Y; Wu YJ; Qiu HR; Shu YQ
    Cancer Genet Cytogenet; 2008 Mar; 181(2):100-7. PubMed ID: 18295661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined study of prostatic carcinoma by classical cytogenetic analysis and comparative genomic hybridization.
    Verdorfer I; Hobisch A; Culig Z; Hittmair A; Bartsch G; Erdel M; Duba HC; Utermann G
    Int J Oncol; 2001 Dec; 19(6):1263-70. PubMed ID: 11713598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis.
    Diaz RJ; Guduk M; Romagnuolo R; Smith CA; Northcott P; Shih D; Berisha F; Flanagan A; Munoz DG; Cusimano MD; Pamir MN; Rutka JT
    Neoplasia; 2012 Sep; 14(9):788-98. PubMed ID: 23019410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.